Metabolic
Metabolic control of innate lymphoid cells in health and disease
Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).
Google Scholar
Spits, H. et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).
Google Scholar
Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015).
Google Scholar
Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765–774 (2016).
Google Scholar
Zhou, L. & Sonnenberg, G. F. Essential immunologic orchestrators of intestinal homeostasis. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aao1605 (2018).
Zhou, L. et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature 568, 405–409 (2019).
Google Scholar
Zhou, L. et al. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation. Nat. Immunol. 23, 251–261 (2022).
Google Scholar
Lyu, M. et al. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. Nature https://doi.org/10.1038/s41586-022-05141-x (2022).
Google Scholar
Zhou, W. et al. ZBTB46 defines and regulates ILC3s that protect the intestine. Nature 609, 159–165 (2022).
Google Scholar
Ouyang, W. & O’Garra, A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50, 871–891 (2019).
Google Scholar
Dudakov, J. A., Hanash, A. M. & van den Brink, M. R. Interleukin-22: immunobiology and pathology. Annu. Rev. Immunol. 33, 747–785 (2015).
Google Scholar
Huang, Y. et al. IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat. Immunol. 16, 161–169 (2015).
Google Scholar
Grigg, J. B. et al. Antigen-presenting innate lymphoid cells orchestrate neuroinflammation. Nature 600, 707–712 (2021).
Google Scholar
Buck, M. D., O’Sullivan, D. & Pearce, E. L. T cell metabolism drives immunity. J. Exp. Med. 212, 1345–1360 (2015).
Google Scholar
Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu. Rev. Immunol. 36, 461–488 (2018).
Google Scholar
Chapman, N. M., Boothby, M. R. & Chi, H. Metabolic coordination of T cell quiescence and activation. Nat. Rev. Immunol. 20, 55–70 (2020).
Google Scholar
O’Brien, K. L. & Finlay, D. K. Immunometabolism and natural killer cell responses. Nat. Rev. Immunol. 19, 282–290 (2019).
Google Scholar
Terren, I. et al. Modulating NK cell metabolism for cancer immunotherapy. Semin. Hematol. 57, 213–224 (2020).
Google Scholar
Gury-BenAri, M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166, 1231–1246 (2016).
Google Scholar
Monticelli, L. A. et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat. Immunol. 17, 656–665 (2016). This paper details arginase 1 as a key metabolic checkpoint that is required to meet the bioenergetic needs of ILC2s during type 2 inflammation.
Google Scholar
Bando, J. K., Nussbaum, J. C., Liang, H. E. & Locksley, R. M. Type 2 innate lymphoid cells constitutively express arginase 1 in the naive and inflamed lung. J. Leukoc. Biol. 94, 877–884 (2013).
Google Scholar
Wilhelm, C. et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213, 1409–1418 (2016). This paper determined that ILC2s robustly utilize fatty acid metabolism for IL-13 production during helminth infection.
Google Scholar
Karagiannis, F. et al. Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation. Immunity 52, 620–634 (2020). This paper identifies that pro-inflammatory ILC2 responses in the airway are regulated by IL-33-induced Pparg and Dgat that subsequently support lipid droplet storage and fatty acid metabolism.
Google Scholar
Surace, L. et al. Dichotomous metabolic networks govern human ILC2 proliferation and function. Nat. Immunol. 22, 1367–1374 (2021). This paper details how human ILC2s exhibit differential dependence of OXPHOS and mTOR signaling for proliferation and cytokine production, respectively.
Google Scholar
Galle-Treger, L. et al. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function. J. Allergy Clin. Immunol. 145, 502–517 (2020).
Google Scholar
Helou, D. G. et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat. Commun. 11, 3998 (2020).
Google Scholar
Fu, L. et al. A mitochondrial STAT3–methionine metabolism axis promotes ILC2-driven allergic lung inflammation. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2021.12.783 (2021).
Google Scholar
Hodge, S. H. et al. Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses. Preprint at BioRxiv https://doi.org/10.1101/2022.06.22.497162 (2022).
Flamar, A. L. et al. Interleukin-33 induces the enzyme tryptophan hydroxylase 1 to promote inflammatory group 2 innate lymphoid cell-mediated immunity. Immunity 52, 606–619 (2020).
Google Scholar
Ricardo-Gonzalez, R. R. et al. Tissue signals imprint ILC2 identity with anticipatory function. Nat. Immunol. 19, 1093–1099 (2018).
Google Scholar
Di Luccia, B., Gilfillan, S., Cella, M., Colonna, M. & Huang, S. C. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J. Exp. Med. 216, 2231–2241 (2019). This paper determined that ILC3s rely on mTORC1 signaling, activation of HIF1α, and mROS production to support optimal responses during an enteric infection.
Google Scholar
Budda, S. A., Girton, A., Henderson, J. G. & Zenewicz, L. A. Transcription factor HIF1α controls expression of the cytokine IL-22 in CD4+ T cells. J. Immunol. 197, 2646–2652 (2016).
Dang, E. V. et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 146, 772–784 (2011).
Google Scholar
Teufel, C. et al. mTOR signaling mediates ILC3-driven immunopathology. Mucosal Immunol. 14, 1323–1334 (2021).
Google Scholar
Fachi, J. L. et al. Hypoxia enhances ILC3 responses through HIF1α-dependent mechanism. Mucosal Immunol. 14, 828–841 (2021).
Google Scholar
Krzywinska, E. et al. The transcription factor HIF1α mediates plasticity of NKp46+ innate lymphoid cells in the gut. J. Exp. Med. https://doi.org/10.1084/jem.20210909 (2022). This paper identifies that intracellular metabolic networks, such as those driven by HIF1α and glycolysis, shape the plasticity ILC3 subsets.
Parker, M. E. et al. c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program. J. Exp. Med. https://doi.org/10.1084/jem.20191030 (2020).
Wu, D. et al. PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation. Nat. Metab. 4, 867–882 (2022). This paper details how PD-1 signaling impacts the cellular metabolism of an ILC3 subset and shapes effector IL-22 production during intestinal inflammation.
Google Scholar
Serafini, N. et al. Trained ILC3 responses promote intestinal defense. Science 375, 859–863 (2022).
Google Scholar
Godinho-Silva, C. et al. Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis. Nature 574, 254–258 (2019).
Google Scholar
Teng, F. et al. A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aax1215 (2019).
Wang, Q. et al. Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aay7501 (2019).
Spencer, S. P. et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343, 432–437 (2014).
Google Scholar
Mielke, L. A. et al. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210, 1117–1124 (2013).
Google Scholar
van de Pavert, S. A. et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508, 123–127 (2014).
Google Scholar
Kim, M. H., Taparowsky, E. J. & Kim, C. H. Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43, 107–119 (2015).
Google Scholar
Konya, V. et al. Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells. J. Allergy Clin. Immunol. 141, 279–292 (2018).
Google Scholar
Lin, Y. D., Arora, J., Diehl, K., Bora, S. A. & Cantorna, M. T. Vitamin D is required for ILC3-derived IL-22 and protection from Citrobacter rodentium infection. Front. Immunol. 10, 1 (2019).
Google Scholar
Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561–1565 (2011).
Google Scholar
Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144–151 (2011).
Google Scholar
Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012).
Google Scholar
Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372–385 (2013).
Google Scholar
Li, S. et al. Aryl hydrocarbon receptor signaling cell intrinsically inhibits intestinal group 2 innate lymphoid cell function. Immunity 49, 915–928 (2018).
Google Scholar
Zhang, L. H., Shin, J. H., Haggadone, M. D. & Sunwoo, J. B. The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells. J. Exp. Med. 213, 2249–2257 (2016).
Google Scholar
Chun, E. et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity 51, 871–884 (2019).
Google Scholar
Fachi, J. L. et al. Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2. J. Exp. Med. https://doi.org/10.1084/jem.20190489 (2020).
Yang, W. et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat. Commun. 11, 4457 (2020).
Google Scholar
Thio, C. L., Chi, P. Y., Lai, A. C. & Chang, Y. J. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate. J. Allergy Clin. Immunol. 142, 1867–1883 (2018).
Google Scholar
Lewis, G. et al. Dietary fiber-induced microbial short-chain fatty acids suppress ILC2-dependent airway inflammation. Front. Immunol. 10, 2051 (2019).
Google Scholar
Li, Y. et al. Natural killer cells: friend or foe in metabolic diseases. Front. Immunol. 12, 614429 (2021).
Google Scholar
O’Sullivan, T. E. et al. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 45, 428–441 (2016).
Google Scholar
Molofsky, A. B. et al. Interleukin-33 and interferon-γ counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 43, 161–174 (2015).
Google Scholar
Boulenouar, S. et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity 46, 273–286 (2017).
Google Scholar
Wang, H. et al. Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nat. Commun. 10, 3254 (2019).
Google Scholar
Cuff, A. O. et al. The obese liver environment mediates conversion of NK cells to a less cytotoxic ILC1-like phenotype. Front. Immunol. 10, 2180 (2019).
Google Scholar
Hildreth, A. D. et al. Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity. Nat. Immunol. 22, 639–653 (2021).
Google Scholar
Moro, K. et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463, 540–544 (2010). This is one of the seminal reports defining ILC2s and reveals their intimate association with adipose tissues.
Google Scholar
Hams, E., Locksley, R. M., McKenzie, A. N. & Fallon, P. G. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 191, 5349–5353 (2013).
Google Scholar
Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535–549 (2013).
Google Scholar
Qiu, Y. et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157, 1292–1308 (2014).
Google Scholar
Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242–246 (2015).
Google Scholar
Lee, M. W. et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74–87 (2015).
Google Scholar
Nguyen, K. D. et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104–108 (2011).
Google Scholar
Fischer, K. et al. Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis. Nat. Med. 23, 623–630 (2017).
Google Scholar
Brestoff, J. R. & Artis, D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146–160 (2015).
Google Scholar
Mahlakoiv, T. et al. Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aax0416 (2019).
Spallanzani, R. G. et al. Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aaw3658 (2019).
Klose, C. S. & Artis, D. Neuronal regulation of innate lymphoid cells. Curr. Opin. Immunol. 56, 94–99 (2019).
Google Scholar
Chu, C., Artis, D. & Chiu, I. M. Neuroimmune interactions in the tissues. Immunity 52, 464–474 (2020).
Google Scholar
Cardoso, F. et al. Neuro-mesenchymal units control ILC2 and obesity via a brain–adipose circuit. Nature 597, 410–414 (2021).
Google Scholar
Sasaki, T. et al. Innate lymphoid cells in the induction of obesity. Cell Rep. 28, 202–217 (2019).
Google Scholar
Dalmas, E. et al. Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production. Immunity 47, 928–942 (2017).
Google Scholar
Newland, S. A. et al. Type 2 innate lymphoid cells control the development of atherosclerosis in mice. Nat. Commun. 8, 15781 (2017).
Google Scholar
O’Leary, C. E. et al. Bile acid-sensitive tuft cells regulate biliary neutrophil influx. Sci. Immunol. 7, eabj1080 (2022).
Google Scholar
Satoh-Takayama, N. et al. Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA. Immunity 52, 635–649 (2020).
Google Scholar
Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54–61 (2014).
Google Scholar
Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237–241 (2014). This paper reveals how the intesinal IL-22 pathway is disrupted in metabolic diseases and how exogenous IL-22 can be harnessed as a therapeutic strategy.
Google Scholar
Hasnain, S. Z. et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat. Med. 20, 1417–1426 (2014).
Google Scholar
Hamaguchi, M. et al. Group 3 innate lymphoid cells protect steatohepatitis from high-fat-diet-induced toxicity. Front. Immunol. 12, 648754 (2021).
Google Scholar
Mao, K. et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature 554, 255–259 (2018). This paper reveals how dynamic cross-talk between innate and adaptive lymphocytes shapes responses to microbiota, and lipid uptake or metabolism.
Google Scholar
Lio, C. J. & Huang, S. C. Circles of life: linking metabolic and epigenetic cycles to immunity. Immunology 161, 165–174 (2020).
Google Scholar
Britt, E. C., John, S. V., Locasale, J. W. & Fan, J. Metabolic regulation of epigenetic remodeling in immune cells. Curr. Opin. Biotechnol. 63, 111–117 (2020).
Google Scholar
Phan, A. T., Goldrath, A. W. & Glass, C. K. Metabolic and epigenetic coordination of T cell and macrophage immunity. Immunity 46, 714–729 (2017).
Google Scholar
Fanucchi, S., Dominguez-Andres, J., Joosten, L. A. B., Netea, M. G. & Mhlanga, M. M. The intersection of epigenetics and metabolism in trained immunity. Immunity 54, 32–43 (2021).
Google Scholar
Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).
Google Scholar
Arguello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063–1075 (2020).
Google Scholar
Subrahmanyam, P. B. & Maecker, H. T. CyTOF measurement of immunocompetence across major immune cell types. Curr. Protoc. Cytom. 82, 9.54.1–9.54.12 (2017).
Hartmann, F. J. et al. Single-cell metabolic profiling of human cytotoxic T cells. Nat. Biotechnol. 39, 186–197 (2021).
Google Scholar
Ganesh, S. et al. Spatially resolved 3D metabolomic profiling in tissues. Sci. Adv. https://doi.org/10.1126/sciadv.abd0957 (2021).
Yuan, Z. et al. SEAM is a spatial single nuclear metabolomics method for dissecting tissue microenvironment. Nat. Methods 18, 1223–1232 (2021).
Google Scholar